Published in Int J Syst Bacteriol on July 01, 1999
Natural history of Bartonella infections (an exception to Koch's postulate). Clin Diagn Lab Immunol (2002) 2.33
Population genetics of the nomenspecies Enterobacter cloacae. Appl Environ Microbiol (2003) 2.29
Potential limitations of the 16S-23S rRNA intergenic region for molecular detection of Bartonella species. J Clin Microbiol (2005) 1.90
cpnDB: a chaperonin sequence database. Genome Res (2004) 1.83
Genomic variation of Bartonella henselae strains detected in lymph nodes of patients with cat scratch disease. J Clin Microbiol (2002) 1.73
16S/23S rRNA intergenic spacer regions for phylogenetic analysis, identification, and subtyping of Bartonella species. J Clin Microbiol (2001) 1.68
Bartonella strains from ground squirrels are identical to Bartonella washoensis isolated from a human patient. J Clin Microbiol (2003) 1.68
Genetic classification and differentiation of Bartonella species based on comparison of partial ftsZ gene sequences. J Clin Microbiol (2002) 1.67
groESL sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci. J Clin Microbiol (2002) 1.45
Bartonella henselae in Ixodes ricinus ticks (Acari: Ixodida) removed from humans, Belluno province, Italy. Emerg Infect Dis (2003) 1.35
Detection and identification of Bartonella species pathogenic for humans by PCR amplification targeting the riboflavin synthase gene (ribC). J Clin Microbiol (2003) 1.34
rpoB sequence analysis of cultured Tropheryma whippelii. J Clin Microbiol (2001) 1.33
Molecular analysis of riboflavin synthesis genes in Bartonella henselae and use of the ribC gene for differentiation of Bartonella species by PCR. J Clin Microbiol (1999) 1.26
Limited diversity among human isolates of Bartonella henselae. J Clin Microbiol (2002) 1.22
Comparison of ileum microflora of pigs fed corn-, wheat-, or barley-based diets by chaperonin-60 sequencing and quantitative PCR. Appl Environ Microbiol (2005) 1.10
Isolation of Bartonella washoensis from a dog with mitral valve endocarditis. J Clin Microbiol (2003) 1.09
Multi-locus sequence typing of a geographically and temporally diverse sample of the highly clonal human pathogen Bartonella quintana. PLoS One (2010) 1.07
Characterization of Bartonella clarridgeiae flagellin (FlaA) and detection of antiflagellin antibodies in patients with lymphadenopathy. J Clin Microbiol (2000) 1.06
Differentiation of pathogenic Bartonella species by infrequent restriction site PCR. J Clin Microbiol (2000) 1.03
Determination of Enterococcus faecalis groESL full-length sequence and application for species identification. J Clin Microbiol (2001) 1.00
Differentiation of rickettsiae by groEL gene analysis. J Clin Microbiol (2003) 1.00
Identification of clinically relevant enterococcus species by direct sequencing of groES and spacer region. J Clin Microbiol (2005) 0.84
Improving the Diagnosis of Scrub Typhus by Combining groEL Based Polymerase Chain Reaction and IgM ELISA. J Clin Diagn Res (2017) 0.75
Isolation of Legionella spp. from environmental water samples by low-pH treatment and use of a selective medium. J Clin Microbiol (1981) 6.88
Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med (1993) 5.45
Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med (1993) 4.88
Caring for pets of immunocompromised persons. J Am Vet Med Assoc (1994) 3.89
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol (1992) 3.81
Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med (1999) 3.45
Distribution, diversity, and host specificity of Bartonella in rodents from the Southeastern United States. Am J Trop Med Hyg (1997) 2.77
An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 2.32
Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J (1998) 2.25
Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med (1995) 2.15
A protective protein antigen of Rickettsia rickettsii has tandemly repeated, near-identical sequences. Infect Immun (1990) 2.14
Genomic fingerprinting of Bartonella species by repetitive element PCR for distinguishing species and isolates. J Clin Microbiol (1995) 2.09
Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis (1999) 2.03
Disseminated cat-scratch disease: detection of Rochalimaea henselae in affected tissue. Eur J Pediatr (1994) 1.92
Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol (1997) 1.91
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Antigenic characteristics of isolates associated with a new epizootic of raccoon rabies in the United States. J Infect Dis (1984) 1.72
PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol (2000) 1.68
Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol (1987) 1.61
Ebola virus: identification of virion structural proteins. J Gen Virol (1980) 1.54
Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis (1998) 1.50
Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis (2001) 1.49
Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol (1999) 1.47
Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis (1996) 1.46
Intradermal use of human diploid cell vaccine for preexposure rabies immunizations. J Am Vet Med Assoc (1982) 1.45
Bartonella henselae endocarditis in an immunocompetent adult. Clin Infect Dis (1995) 1.36
Epidemiologic observations on infection with Rochalimaea species among cats living in Baltimore, Md. J Am Vet Med Assoc (1994) 1.33
Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease. Pediatrics (1995) 1.33
Serologic evidence of infection with Ehrlichia spp. in wild rodents (Muridae: Sigmodontinae) in the United States. J Clin Microbiol (1998) 1.32
Cat-scratch disease in Hawaii: etiology and seroepidemiology. J Pediatr (1995) 1.31
Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clin Infect Dis (1995) 1.29
In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers. Antimicrob Agents Chemother (1997) 1.27
Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island. J Clin Microbiol (1997) 1.26
Prevalence of antibodies to Rochalimaea species (cat-scratch disease agent) in cats. Vet Rec (1995) 1.26
Dusky-footed wood rats (Neotoma fuscipes) as reservoirs of granulocytic Ehrlichiae (Rickettsiales: Ehrlichieae) in northern California. J Clin Microbiol (1999) 1.25
Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med (1996) 1.24
Bartonella henselae, B. quintana, and B. bacilliformis: historical pathogens of emerging significance. Microbes Infect (2000) 1.24
Serodiagnosis of Bartonella bacilliformis infection by indirect fluorescence antibody assay: test development and application to a population in an area of bartonellosis endemicity. J Clin Microbiol (2000) 1.20
Will the real agent of cat-scratch disease please stand up? Annu Rev Microbiol (1996) 1.19
Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med (1986) 1.16
Virion nucleic acid of Ebola virus. J Virol (1980) 1.15
Case 22-1992--pathogenesis of cat scratch disease. N Engl J Med (1992) 1.13
Isolation of Bartonella spp. from embryos and neonates of naturally infected rodents. J Wildl Dis (1998) 1.10
Flying squirrel-associated Rickettsia prowazekii (epidemic typhus rickettsiae) characterized by a specific DNA fragment produced by restriction endonuclease digestion. J Clin Microbiol (1986) 1.10
Further analyses of the orthopoxviruses volepox virus and raccoon poxvirus. Virology (1992) 1.09
Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol (2001) 1.07
Prevalence of Bartonella henselae and Bartonella clarridgeiae in an urban Indonesian cat population. Clin Diagn Lab Immunol (1999) 1.07
Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol (1999) 1.06
Bartonella henselae isolated from cats in Zimbabwe. Lancet (1998) 1.06
Isolation of Bartonella (Rochalimaea) henselae: effects of methods of blood collection and handling. J Clin Microbiol (1997) 1.06
Differentiation of pathogenic Bartonella species by infrequent restriction site PCR. J Clin Microbiol (2000) 1.03
Prospective assessment of the etiology of acute febrile illness after a tick bite in Slovenia. Clin Infect Dis (2001) 1.02
Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum. J Clin Microbiol (1999) 0.98
Enzyme immunoassay for rabies antibody in hybridoma culture fluids and its application to differentiation of street and laboratory strains of rabies virus. J Clin Microbiol (1984) 0.97
Characterization of Bartonella henselae-specific immunity in BALB/c mice. Immunology (1999) 0.96
Extensive lesions of monkeypox in a prairie dog (Cynomys sp). Vet Pathol (2004) 0.96
Caring for pets of immunocompromised persons. Can Vet J (1995) 0.95
Genotypic evaluation of rickettsial isolates recovered from various species of ticks in Portugal. Epidemiol Infect (1995) 0.94
Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus. J Clin Microbiol (1990) 0.93
Experimental infection of cotton rats with three naturally occurring Bartonella species. J Wildl Dis (1999) 0.93
Cluster of five children with acute encephalopathy associated with cat-scratch disease in south Florida. Pediatr Infect Dis J (1995) 0.93
Characterization of human immunoglobulin (Ig) isotype and IgG subclass response to Bartonella henselae infection. Infect Immun (1998) 0.92
Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. J Virol (1991) 0.92
In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected vero cell monolayers. J Antimicrob Chemother (2000) 0.91
Human ehrlichiosis in central Europe. Wien Klin Wochenschr (1998) 0.90
Shared vector-borne zoonoses of the Old World and New World: home grown or translocated? Schweiz Med Wochenschr (1999) 0.88
Detection of antibodies reactive with Ehrlichia chaffeensis in the raccoon. J Wildl Dis (2000) 0.88
Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein. J Wildl Dis (1991) 0.86
In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. Int J Antimicrob Agents (2001) 0.86
Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. J Virol (1992) 0.85
Polysomal RNA in Semliki Forest virus infected Aedes albopictus cells. J Gen Virol (1975) 0.84
Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries. Am J Trop Med Hyg (1985) 0.84
A proposed index system for reporting rabies rapid fluorescent focus inhibition test titres. J Biol Stand (1984) 0.82
Ehrlichia chaffeensis and Rochalimaea antibodies in Kawasaki disease. J Clin Microbiol (1993) 0.78
Microneutralization test for rabies virus based on an enzyme immunoassay. J Clin Microbiol (1987) 0.78
Analysis of Rickettsia tsutsugamushi amplified DNA that encodes an antigenic gene product. Ann N Y Acad Sci (1990) 0.77
Pathogen prevalence and blood meal identification in Amblyomma ticks as a means of reservoir host determination for ehrlichial pathogens. Clin Microbiol Infect (2009) 0.76
Intradermal immunization with human diploid cell rabies vaccine: serological and clinical responses of immunized persons to intradermal booster vaccination. Am J Public Health (1984) 0.75
Development of an immunofluorescence focus assay for Ebola virus. J Clin Microbiol (1983) 0.75
Preliminary studies on an unusual poxvirus of the western grey squirrel (Sciurus griseus griseus) of North America. Intervirology (1975) 0.75
The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am J Trop Med Hyg (1986) 0.75